Opioid Dependence Treatment Market Size

  • Report ID: 4003
  • Published Date: Nov 15, 2024
  • Report Format: PDF, PPT

Opioid Dependence Treatment Market Size

Opioid Dependence Treatment Market size was over USD 3.61 billion in 2024 and is anticipated to cross USD 11.61 billion by 2037, growing at more than 9.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of opioid dependence treatment is assessed at USD 3.88 billion.

The growth of this market is driven by the increasing number of people all over the world getting addicted to opioids. This number has been increasing at a steady pace over the years. According to the World Health Organization (WHO), there were approximately 53 million opioid users worldwide in 2019. This has increased the demand for opioid addiction treatment. 

Moreover, the market is also anticipated to grow with rising government initiatives regarding opioid dependency treatment. The government authorities of various regions across the globe time and again have identified the need for an opioid shortage and have adopted multiple initiatives and programs to promote opioid dependency treatment all over the world. In the United States, the Substance Abuse and Mental Health Services Administration (SAMHSA) has allocated funds to support drug-assisted treatment (MAT) for opioid addiction. 


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4003
  • Published Date: Nov 15, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of opioid dependence treatment is assessed at USD 3.88 billion.

The opioid dependence treatment market size was over USD 3.61 billion in 2024 and is anticipated to cross USD 11.61 billion by 2037, growing at more than 9.4% CAGR during the forecast period i.e., between 2025-2037. The market growth is impelled by increasing number of cases of opioid abuse and addictions among people worldwide and favorable reimbursements for smoking cessation therapy.

Asia Pacific industry is set to account for largest revenue share of 39% by 2037, owing to increasing number of people suffering from opioid dependency, and high emphasis of government to tackle the same.

The major players in the market are Orexo AB, Indivior PLC, Titan Pharmaceuticals, Inc., Viatris Inc., Pfizer, Inc., Hikma Pharmaceuticals PLC, BioDelivery Sciences International Inc., Teva Pharmaceutical Industries Ltd., Alkermes, Camurus AB
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample